Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer

Colin D. Weekes; Laetitia E. Lamberts; Mitesh J. Borad; Johannes Voortman; Robert R. McWilliams; Jennifer R. Diamond; Elisabeth G. E. de Vries; Henk M. Verheul; Christopher H. Lieu; George P. Kim; Yulei Wang; Suzie J. Scales; Divya Samineni; Flavia Brunstein; YounJeong Choi; Daniel J. Maslyar; Gerardo Colon-Otero

doi:https://doi.org/10.1158/1535-7163.MCT-15-0693

Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer

Colin D. Weekes, Laetitia E. Lamberts, Mitesh J. Borad, Johannes Voortman, Robert R. McWilliams, Jennifer R. Diamond, Elisabeth G. E. de Vries, Henk M. Verheul, Christopher H. Lieu, George P. Kim, Yulei Wang, Suzie J. Scales, Divya Samineni, Flavia Brunstein, YounJeong Choi, Daniel J. Maslyar, Gerardo Colon-Otero

Medical oncology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

82 Citations (Scopus)

Original language	English
Pages (from-to)	439-447
Journal	Molecular Cancer Therapeutics
Volume	15
Issue number	3
DOIs	https://doi.org/10.1158/1535-7163.MCT-15-0693
Publication status	Published - Mar 2016

Access to Document

https://doi.org/10.1158/1535-7163.MCT-15-0693

Cite this

Weekes, C. D., Lamberts, L. E., Borad, M. J., Voortman, J., McWilliams, R. R., Diamond, J. R., de Vries, E. G. E., Verheul, H. M., Lieu, C. H., Kim, G. P., Wang, Y., Scales, S. J., Samineni, D., Brunstein, F., Choi, Y., Maslyar, D. J., & Colon-Otero, G. (2016). Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer. Molecular Cancer Therapeutics, 15(3), 439-447. https://doi.org/10.1158/1535-7163.MCT-15-0693

@article{601e2ed629b74241a0ad4b80253c13fd,

title = "Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer",

author = "Weekes, {Colin D.} and Lamberts, {Laetitia E.} and Borad, {Mitesh J.} and Johannes Voortman and McWilliams, {Robert R.} and Diamond, {Jennifer R.} and {de Vries}, {Elisabeth G. E.} and Verheul, {Henk M.} and Lieu, {Christopher H.} and Kim, {George P.} and Yulei Wang and Scales, {Suzie J.} and Divya Samineni and Flavia Brunstein and YounJeong Choi and Maslyar, {Daniel J.} and Gerardo Colon-Otero",

year = "2016",

month = mar,

doi = "https://doi.org/10.1158/1535-7163.MCT-15-0693",

language = "English",

volume = "15",

pages = "439--447",

journal = "Molecular Cancer Therapeutics",

issn = "1535-7163",

publisher = "American Association for Cancer Research Inc.",

number = "3",

}

Weekes, CD, Lamberts, LE, Borad, MJ, Voortman, J, McWilliams, RR, Diamond, JR, de Vries, EGE, Verheul, HM, Lieu, CH, Kim, GP, Wang, Y, Scales, SJ, Samineni, D, Brunstein, F, Choi, Y, Maslyar, DJ & Colon-Otero, G 2016, 'Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer', Molecular Cancer Therapeutics, vol. 15, no. 3, pp. 439-447. https://doi.org/10.1158/1535-7163.MCT-15-0693

Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer. / Weekes, Colin D.; Lamberts, Laetitia E.; Borad, Mitesh J. et al.
In: Molecular Cancer Therapeutics, Vol. 15, No. 3, 03.2016, p. 439-447.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer

AU - Weekes, Colin D.

AU - Lamberts, Laetitia E.

AU - Borad, Mitesh J.

AU - Voortman, Johannes

AU - McWilliams, Robert R.

AU - Diamond, Jennifer R.

AU - de Vries, Elisabeth G. E.

AU - Verheul, Henk M.

AU - Lieu, Christopher H.

AU - Kim, George P.

AU - Wang, Yulei

AU - Scales, Suzie J.

AU - Samineni, Divya

AU - Brunstein, Flavia

AU - Choi, YounJeong

AU - Maslyar, Daniel J.

AU - Colon-Otero, Gerardo

PY - 2016/3

Y1 - 2016/3

U2 - https://doi.org/10.1158/1535-7163.MCT-15-0693

DO - https://doi.org/10.1158/1535-7163.MCT-15-0693

M3 - Article

C2 - 26823490

SN - 1535-7163

VL - 15

SP - 439

EP - 447

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

IS - 3

ER -